Sentences with phrase «drug companies spend»

As an aside, drug companies spend many millions of dollars before they are able to bring a new drug to market in this country.

He argued the drug companies spent millions of dollars to promote the drugs for profit while denying or trivializing their potential addictive qualities.

In 2017, the first year of the Trump administration, the 10 largest drug companies spent a combined $ 74 million.

Last year, as pressure mounted on the pharmaceutical industry after a series of high profile cases involving skyrocketing prices, drug companies spent roughly $ 800,000 lining campaign coffers in Albany.

Not exact matches

«And as long as that happens, your insurance company is not going to pay your bill if you take a drug and the pharmaceuticals are not going to develop the drugs because if nobody is going to pay for their use, why spend the money on that?»

Before the insurance company pays a penny toward drugs, she and her husband have to spend $ 7,000 each year.

Eagle's Sassouni pointed out that since the big drug companies are losing billions of dollars every year to generic versions and have little to spend on their own research and development, they are looking to buy smaller biotechnology companies that are developing their own products.

But here's the problem for Valeant: According to its income statement, it spends just 3 % of its revenue on R&D, compared to about 15 % to 20 % for large drug companies.

According to Ackman, Valeant has spent $ 40 billion acquiring drugs or drug companies in the past five years or so.

In late 2015 the company acquired Cordis, naviHealth, and Harvard Drug; it spent much of 2016 integrating them, with a 19 % increase in annual revenue to show for it.

Much of the problem, Miller explained, is that Americans are already shouldering more than their fair share of pharmaceutical companies» costs: While the U.S, accounts for only 4.6 % of the total world population, it makes up about 40 % of the world's drug spending, and the bulk of pharma companies» profits, he said.

By adding a health insurance company in the form of Aetna, the resulting combination — retailer, clinic operator, pharmacy benefits manager, and insurer — can realize significant efficiencies, negotiate for lower drug prices with pharmaceutical manufacturers, and capture the growing share of healthcare spend among consumers and employers.

Athenex, which raised $ 68 million from a secondary stock offering during the quarter, finished the year with $ 51 million in cash and short - term investments, down from $ 69 million in September as the company spent heavily on clinical trials for the drugs it is developing and absorbed higher licensing fees at its specialty drug business, which has added 12 new drugs to its stable of products.

It's hard to imagine anybody making a trip to Walgreens because the company spent $ 17 billion - plus to boost its stake in a drug wholesaler to 100 percent from 26 percent.

That may come as a surprise amid hand - wringing about the spiraling cost of health care, but two new studies, one from research company IMS Health and one from pharmacy benefit manager Express Scripts, show that the amount of money Americans spend on prescription drugs went down in 2012 for the first time in decades.

Large companies (Big Pharma) spend considerable amounts on advertising and distribution, and often have large sales forces that promote their drugs to physicians to convince them to prescribe the drug.

Pharmaceutical Research and Manufacturers of America, or PhRMA, the trade group that advocates for drug companies, spent almost $ 10 million on lobbying in the first quarter of 2018, according to the Center for Responsive Politics.

That cash doesn't include the money PhRMA's spending on the ongoing «Go Boldly» campaign, a series of TV, print and radio ads designed to polish the drug industry's image by reminding the public that drug companies do world - class research that brings disease cures to market to save lives.

A 2017 investigation into lobbying efforts by «Big Pharma» conducted by The Washington Post and 60 Minutes found that the companies spent more than $ 106 million to lobby Congress in an effort to pass more favorable drug laws.

Long Island's two medical marijuana dispensaries are scheduled to open today, after companies authorized to sell the drug spent months navigating bureaucratic roadblocks and community anxieties.

Gov. Cuomo on Thursday will visit Dunkirk to formally unveil the state's plans to spend $ 200 million to build a high - tech drug manufacturing center there for a Buffalo biotech company.

Although the pharmaceutical industry, like the rest of the business world, has suffered a slowdown, the market research company Frost and Sullivan still expects spending on drug discovery to expand from US$ 19.6 billion in 2002 to US$ 25.6 billion by 2006, an annual growth rate of about 6 %.

Tabash has his own postdoctoral project that he developed with input from his advisor, but he also spends a portion of his time assisting in the company's drug discovery and development platform — its «lifeline» work.

In the 1990s, a handful of drug companies, including Novartis, had collectively spent north of $ 2 billion to use genetic manipulation to make human - friendly pig organs.

Drug companies have spent vast amounts of time and money trying and failing to reproduce potential drug targets reported in the scientific literature — resources that should have contributed towards curing diseaDrug companies have spent vast amounts of time and money trying and failing to reproduce potential drug targets reported in the scientific literature — resources that should have contributed towards curing diseadrug targets reported in the scientific literature — resources that should have contributed towards curing diseases.

Duncan, who spent 16 years at GlaxoSmithKline working on diseases of the developing world, says companies in the TB Drug Accelerator program have an unusually open agreement.

In the meantime, Merck spent $ 100 million a year on consumer advertising for the drug — more than Pepsi spent for its cola — and published more company - funded studies that obscured potentially deadly side effects.

Other analysts have also noted that while research and development spending by pharmaceutical companies has increased dramatically, the number of new drug approvals has remained flat.»

«I've always believed it's scientifically possible to enhance cognition, but society will have to decide whether it wants these drugs,» says Keith Wesnes, a psychologist who spent 10 years studying the effects of nicotine on attention and memory at British universities and who now runs Cognition Drug Research, a Reading - based company similar to Crook's.

Among the interesting topics covered in Pathways are: the changing role of the patient in the total health equation and the ways in which decentralized information is affecting their expectations and demands; the dearth of pipeline products among international pharmaceutical companies against a backdrop of increased research and development spending; the dynamics of emerging markets and their rising demand for therapies in chronic disease; the value of drugs and biotechnology solutions within the context of global economic realities.

Alternatively, they suggest spending less, around $ 1 billion, for a less radical change in marketing: the global authority would have a say in how the drug was sold, but the company that developed it could still sell it for a profit.

He spent 20 years as a toxicologist at various pharmaceutical companies and now consults in that industry, advising companies on whether a potential drug may cause liver problems.

Drug companies had long ago given up on targeting RAS, however, because it doesn't have an obvious pocket, or binding site, that a drug could fit into to block its activity, says Frank McCormick, who recently stepped down as director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, to spend half his time directing NCI's RAS projDrug companies had long ago given up on targeting RAS, however, because it doesn't have an obvious pocket, or binding site, that a drug could fit into to block its activity, says Frank McCormick, who recently stepped down as director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, to spend half his time directing NCI's RAS projdrug could fit into to block its activity, says Frank McCormick, who recently stepped down as director of the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, to spend half his time directing NCI's RAS project.

Pfizer, the world's largest drug company, and one that's proud of its scientific acumen, announced yesterday that it will cut R&D spending in 2012 by about 20 %, from $ 8.5 billion to $ 7 billion.

That's part of the reason that most drugs that work in animals don't work in people — only 11 % of oncology compounds that show promise in mice are ever approved for humans — despite billions of dollars spent by pharmaceutical and biotech companies.

C. Glenn Begley, who spent a decade in charge of global cancer research at the biotech giant Amgen, recently dispatched 100 Amgen scientists to replicate 53 landmark experiments in cancer — the kind of experiments that lead pharmaceutical companies to sink millions of dollars to turn the results into a drug.

Why muscles wither with age is captivating a growing number of scientists, drug and food companies, let alone aging baby boomers who, despite having spent years sweating in the gym, are confronting the body's natural loss of muscle tone over time.

It has only just dawned on us that menstruation, pregnancy, and childbirth are not diseases; now we need to realize that menopause is not a disease despite millions in advertising dollars spent by drug companies to convince us otherwise.

Pharmaceutical companies that spend billions to develop patented — and expensive — cancer drugs have little incentive to fund or conduct studies on generics like metformin.

hello easy going retired auto worker with small online solar sales company as a hobby I an 52 i have a income, a home, i am drug free, smoke free, am looking for a nice lady to spend the rest of my life with here in the state of michigan SKYPE ME AT TIMOTHY26372 OR [email protected]

The film is as contemptuous of the rapacious and deceitful Texan oil executives who have put Peter's company out of business as it is of the rebel kidnappers, a band of Marxist revolutionaries so thoroughly corrupted by their drug and kidnapping operations that they now spend much of their time getting high.

But it doesn't make much sense to me to liquidate a company that has been given cash for the specific purpose of spending it to develop drugs.

It is a biotech company created to spend cash to try to come up with new drugs.

The company continues to spend down its cash hoard, albeit at a diminishing rate, on drug development and testing.

The «Getting Health Care Spending Under Control» section of the plan is one paragraph long and offers little beyond assurances that «creating a single public insurance system will go a long way towards getting health care spending under control» and under Berniecare «government will finally be able to stand up to drug companiesSpending Under Control» section of the plan is one paragraph long and offers little beyond assurances that «creating a single public insurance system will go a long way towards getting health care spending under control» and under Berniecare «government will finally be able to stand up to drug companiesspending under control» and under Berniecare «government will finally be able to stand up to drug companies.»

While pharmaceutical companies argue the price of of drugs reflects what they spend researching and developing new treatments, a study published Monday in JAMA Internal Medicine says the cost of developing a cancer drug is much lower than previously estimated.

While the companies spent $ 9 billion developing the drugs, they have made $ 67 billion in revenue so far, a more than seven-fold return.

Aside from integrating the companies into its own business, the beauty giant helped merchandise the products in drug stores in ways that enhanced customers» shopping experiences and kept them spending.